**
Emerging research from Mount Sinai has unveiled a concerning reality regarding fetal exposure to per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals.” A comprehensive analysis of umbilical cord blood samples has detected a significantly broader range of these harmful compounds than previously recognised. This finding raises critical questions about the potential health implications for newborns.
Expanded Research Findings
Traditionally, testing of umbilical cord blood has focused primarily on a limited selection of PFAS compounds, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, the recent study broadened its scope to include a non-targeted analysis of 120 umbilical cord blood samples, leading researchers to identify 42 distinct PFAS compounds. The results indicate that the total concentration of these chemicals in fetal blood is substantially higher than earlier estimates suggested.
Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and co-author of the study, highlighted the implications of these findings: “Babies are exposed to many more PFAS than we previously thought. It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.”
Health Risks Associated with PFAS
PFAS are a group of over 15,000 synthetic chemicals that are widely used in various industries due to their water-, stain-, and grease-resistant properties. They have been linked to serious health issues, including cancer, birth defects, weakened immune responses, high cholesterol, and kidney disease. Given their persistence in the environment—hence the term “forever chemicals”—the potential for cumulative exposure is concerning, especially for developing fetuses.
A comprehensive review of existing studies has revealed that PFAS have been detected in approximately 30,000 umbilical cord blood samples, indicating widespread exposure. Elevated levels of these chemicals in pregnant individuals have been correlated with higher infant mortality rates, low birth weight, and increased risks of obesity in later life. Moreover, fetal exposure to PFAS has been associated with long-term health complications, including cancer and neurological disorders.
Regulatory Gaps and the Need for Action
The regulatory landscape surrounding PFAS has struggled to keep pace with the rapid proliferation of these chemicals. The U.S. Environmental Protection Agency (EPA), for instance, has primarily focused on a limited number of PFAS compounds in their water testing protocols, which typically encompass only 30 to 40 substances. However, independent research has uncovered thousands of PFAS in environmental samples, underscoring a significant gap in monitoring and regulation.
Mount Sinai’s study has effectively demonstrated the inadequacies of traditional testing methodologies by comparing the results from the old analytical techniques with the new non-targeted approach. Liu noted that while the EPA has recently approved a blood test for 53 compounds, their methodology still overlooks 31 compounds identified in the Mount Sinai analysis, highlighting a critical need for more comprehensive testing frameworks.
Implications for Future Research
While this study does not directly link the detected PFAS levels to specific health outcomes, the correlation between higher PFAS concentrations and health risks is well-established. The blood samples analysed were part of the federal government’s Home Study, which tracks PFAS exposure and health outcomes over time. Researchers at Mount Sinai plan to further investigate the health implications of these findings to better understand the long-term effects on children.
David Andrews, acting chief science officer at the Environmental Working Group, remarked on the significance of the study, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The revelation that fetuses are likely exposed to a far greater array of PFAS chemicals than previously understood is alarming. It not only illuminates the inadequacies in current testing and regulatory practices but also underscores the urgent need for reform in how these chemicals are monitored and managed. As public health implications unfold, it is crucial to advocate for stronger regulations to safeguard vulnerable populations, particularly unborn children, from the detrimental effects of persistent environmental pollutants.
